Lastly, mitochondrial damage and morphological abnormalities are implicated in patients with sporadic and familial AD and factors such as dynamin-related protein 1 (Drp1), are known to protect against AD-related mitochondrial toxicities [80,81]. This evidence concerns the gene DNM1L and Alzheimer disease.